UBS Group
HIT

UBS Group’s Health In Tech Inc HIT Stock Holding History

UBS Group’s Portfolio HIT Stock Details HIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.9K Sell
8,203
-395,953
-98% -$575K ﹤0.01% 8275
2025
Q4 		$643K Buy
404,156
+294,440
+268% +$643K ﹤0.01% 5928
2025
Q3 		$352K Sell
109,716
-17,059
-13% -$40.9K ﹤0.01% 6332
2025
Q2 		$112K Buy
126,775
+26,600
+27% +$17.7K ﹤0.01% 7144
2025
Q1 		$66.3K Buy
100,175
+97,839
+4,188% +$471K ﹤0.01% 7367
2024
Q4 		$12.5K Buy
+2,336
New +$12.5K ﹤0.01% 8192

Other funds holding HIT

MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group's HIT Position: Q1 2026 in Review

UBS Group reduced its Health In Tech Inc (HIT) stake by 98% in Q1 2026, selling an estimated $575K and leaving 8,203 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #8275.

UBS Group first reported a position in HIT in Q4 2024 and has held it in 6 quarters since. The position peaked at $643K in Q4 2025. 15 funds tracked by Wall St. Rank hold HIT as of Q1 2026.

  • UBS Group held 8,203 shares of Health In Tech Inc worth $11.9K as of Q1 2026.
  • UBS Group sold 395,953 Health In Tech Inc shares in Q1 2026, an estimated $575K.
  • Health In Tech Inc made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8275 holding.
  • UBS Group first reported a position in Health In Tech Inc in Q4 2024 and has held it in 6 quarters since.
  • UBS Group's Health In Tech Inc position peaked at $643K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Health In Tech Inc as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.